• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在患有或不患有子痫前期的妊娠中,母体胎盘生长因子(PlGF)和可溶性血管内皮生长因子受体-1(sFlt-1)与低出生体重和/或小于胎龄儿相关。

Maternal PlGF and sFlt-1 are Associated with Low Birth Weight and/or Small-for-Gestational Age Neonates in Pregnancy with or without Preeclampsia.

作者信息

Luo Wenbo, Tang Pingping, Lv Yan, Song Yijun, Hu Huiying, Gao Jinsong, Liu Juntao

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Obstetric and Gynecologic Diseases, Beijing, China.

出版信息

AJP Rep. 2025 Mar 31;15(1):e36-e42. doi: 10.1055/a-2555-1742. eCollection 2025 Jan.

DOI:10.1055/a-2555-1742
PMID:40166700
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11957859/
Abstract

OBJECTIVE

To evaluate the association of PIGF and sFlt-1 with low birth weight and/or small-for-gestational age neonates in pregnancy with or without preeclampsia.

METHODS

Singleton pregnancies with sFlt-1/PlGF tested were included and set into four groups for case-control analysis. Distribution of sFlt-1/PlGF, sFlt-1, PlGF, and PGF% were evaluated, Kruskal-Wallis test and Mann-Whitney U test were adopted for significance analysis.

RESULTS

Maternal sFlt-1/PlGF, PlGF, PlGF%, and sFlt-1 were statistically associated with low birth weight and/or small-for-gestational age in pregnancy complicated or uncomplicated with preeclampsia. A significant difference was shown on sFlt-1/PIGF (  = 0.0082), PIGF% (  = 0.0326), PIGF (  = 0.0128), and sFlt-1 (  = 0.0469) in pregnancy with small-for-gestational age and/or low birth weight neonates. A significantly higher median of sFlt-1/PlGF (448 vs. 61.6,  < 0.0001) and sFlt-1 (15499 vs. 3226,  < 0.0001), a significantly lower median of PlGF (33.92 vs. 115.2,  < 0.0001) and PlGF% (-76.63 vs. -20.31,  < 0.0001) were demonstrated, respectively, when preeclampsia with small-for-gestational age and/or low birth weight neonates was compared with preeclampsia with normal birth weight neonates. No significant difference was demonstrated between low birth weight and small-for-gestational age on sFlt-1/PlGF, PlGF, PlGF%, and sFlt-1.

CONCLUSION

sFlt-1/PlGF seems to be a promising biomarker in predicting low birth weight and/or small-for-gestational age neonates in pregnancy with or without preeclampsia.

摘要

目的

评估胎盘生长因子(PIGF)和可溶性血管内皮生长因子受体-1(sFlt-1)与患有或未患有子痫前期的妊娠中低出生体重和/或小于胎龄新生儿的相关性。

方法

纳入进行了sFlt-1/胎盘生长因子(PlGF)检测的单胎妊娠,并分为四组进行病例对照分析。评估sFlt-1/PlGF、sFlt-1、PlGF和PGF%的分布情况,采用Kruskal-Wallis检验和Mann-Whitney U检验进行显著性分析。

结果

在患有或未患有子痫前期的妊娠中,母体sFlt-1/PlGF、PlGF、PlGF%和sFlt-1与低出生体重和/或小于胎龄具有统计学相关性。在小于胎龄和/或低出生体重新生儿的妊娠中,sFlt-1/PIGF(P = 0.0082)、PIGF%(P = 0.0326)、PIGF(P = 0.0128)和sFlt-1(P = 0.0469)显示出显著差异。与出生体重正常的子痫前期新生儿相比,患有小于胎龄和/或低出生体重新生儿的子痫前期患者中,sFlt-1/PlGF(448对61.6,P < 0.0001)和sFlt-1(15499对3226,P < 0.0001)的中位数显著更高,PlGF(33.92对115.2,P < 0.0001)和PlGF%(-76.63对-20.31,P < 0.0001)的中位数显著更低。在低出生体重和小于胎龄之间,sFlt-1/PlGF、PlGF、PlGF%和sFlt-1未显示出显著差异。

结论

sFlt-1/PlGF似乎是预测患有或未患有子痫前期妊娠中低出生体重和/或小于胎龄新生儿的一个有前景的生物标志物。

相似文献

1
Maternal PlGF and sFlt-1 are Associated with Low Birth Weight and/or Small-for-Gestational Age Neonates in Pregnancy with or without Preeclampsia.在患有或不患有子痫前期的妊娠中,母体胎盘生长因子(PlGF)和可溶性血管内皮生长因子受体-1(sFlt-1)与低出生体重和/或小于胎龄儿相关。
AJP Rep. 2025 Mar 31;15(1):e36-e42. doi: 10.1055/a-2555-1742. eCollection 2025 Jan.
2
Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 可作为预测子痫前期的有用标志物,但不能作为预测小于胎龄儿的标志物:一项纵向研究。
Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):225-30. doi: 10.1016/j.ejogrb.2013.08.040. Epub 2013 Sep 4.
3
Circulating soluble fms-like tyrosine kinase-1 and placental growth factor from 10 to 40 weeks' pregnancy in normotensive women.正常血压孕妇妊娠10至40周时循环可溶性fms样酪氨酸激酶-1和胎盘生长因子的情况。
J Perinat Med. 2017 Oct 26;45(7):895-901. doi: 10.1515/jpm-2017-0093.
4
Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?子痫前期和胎儿生长受限中的尿胎盘生长因子:循环生物标志物的替代物?
J Obstet Gynaecol Res. 2019 Sep;45(9):1828-1836. doi: 10.1111/jog.14038. Epub 2019 Jul 1.
5
Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.可溶性fms样酪氨酸激酶1在子痫前期升高,但在足月小样儿的血压正常妊娠中不升高:与循环胎盘生长因子的关系。
J Clin Endocrinol Metab. 2005 Aug;90(8):4895-903. doi: 10.1210/jc.2004-1955. Epub 2005 May 10.
6
Correlation of sFlt/PlGF ratio with severity of preeclampsia in an Indian population.印度人群中可溶性血管内皮生长因子受体1/胎盘生长因子比值与子痫前期严重程度的相关性
AJOG Glob Rep. 2023 Feb 7;3(2):100177. doi: 10.1016/j.xagr.2023.100177. eCollection 2023 May.
7
Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.重度子痫前期与正常妊娠中胎盘可溶性fms样酪氨酸激酶-1(sFlt-1)、胎盘生长因子(PlGF)浓度及sFlt-1/PlGF比值的差异
BMC Res Notes. 2015 Oct 4;8:534. doi: 10.1186/s13104-015-1506-0.
8
Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.预测小于胎龄儿:35-37 周时胎盘生长因子和可溶性 fms 样酪氨酸激酶-1 的筛查。
Ultrasound Obstet Gynecol. 2015 Aug;46(2):191-7. doi: 10.1002/uog.14862. Epub 2015 Jun 18.
9
Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.可溶性 fms 样酪氨酸激酶与胎盘生长因子比值在不同时期的胎儿生长受限及小于胎龄儿中的变化。
Acta Obstet Gynecol Scand. 2021 Jan;100(1):119-128. doi: 10.1111/aogs.13978. Epub 2020 Sep 14.
10
The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.可溶性fms样酪氨酸激酶-1(sFLT-1)与胎盘生长因子(PIGF)的比值作为子痫前期严重程度的可能指标——单机构经验
Med Glas (Zenica). 2019 Feb 1;16(1):53-59. doi: 10.17392/994-19.

引用本文的文献

1
Predictive accuracy of sFlt-1/PlGF ratio for preeclampsia and adverse outcomes: prospective, multicenter including primary, secondary, and tertiary care institutions, observational study in Japan.可溶性血管内皮生长因子受体-1(sFlt-1)与胎盘生长因子(PlGF)比值对先兆子痫及不良结局的预测准确性:日本一项前瞻性、多中心(包括一级、二级和三级医疗机构)观察性研究。
Hypertens Res. 2025 Aug 4. doi: 10.1038/s41440-025-02282-0.

本文引用的文献

1
Predictive and Diagnostic Value of the Angiogenic Proteins in Patients With Chronic Kidney Disease.血管生成蛋白在慢性肾脏病患者中的预测和诊断价值。
Hypertension. 2024 Nov;81(11):2251-2262. doi: 10.1161/HYPERTENSIONAHA.124.23411. Epub 2024 Aug 20.
2
Letter to the editor: Caution: Not all sFlt-1/PlGF ratios are the same.致编辑的信:注意:并非所有的可溶性血管内皮生长因子受体-1/胎盘生长因子比值都相同。
Pregnancy Hypertens. 2024 Sep;37:101149. doi: 10.1016/j.preghy.2024.101149. Epub 2024 Aug 14.
3
Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy.
血清可溶性fms样酪氨酸激酶1/胎盘生长因子检测在妊娠高血压疾病住院女性常规临床评估中的应用的真实世界证据。
Am J Obstet Gynecol. 2025 Apr;232(4):385.e1-385.e21. doi: 10.1016/j.ajog.2024.07.015. Epub 2024 Jul 17.
4
sFlt-1/PlGF ratio predicts serious outcomes in confirmed early-onset preeclampsia.sFlt-1/PlGF 比值可预测确诊的早发型子痫前期的严重结局。
Eur J Obstet Gynecol Reprod Biol. 2024 Sep;300:159-163. doi: 10.1016/j.ejogrb.2024.07.023. Epub 2024 Jul 11.
5
Maternal serum biomarkers of placental insufficiency at 24-28 weeks of pregnancy in relation to the risk of delivering small-for-gestational-age infant in Sylhet, Bangladesh: a prospective cohort study.妊娠 24-28 周孕妇血清胎盘功能不全标志物与孟加拉国锡尔赫特小于胎龄儿风险的关系:一项前瞻性队列研究。
BMC Pregnancy Childbirth. 2024 Jun 10;24(1):418. doi: 10.1186/s12884-024-06588-8.
6
The sFLT-1/PlGF Ratio for the Prediction of Preeclampsia-Related Adverse Fetal and Maternal Outcomes in Women with Preexisting Diabetes.sFlt-1/PlGF 比值预测伴有糖尿病的子痫前期孕妇不良母婴结局
Reprod Sci. 2024 Aug;31(8):2371-2378. doi: 10.1007/s43032-024-01540-9. Epub 2024 Apr 11.
7
Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.使用母体 PlGF 和 sFlt-1/PlGF 比值预测生长受限和适于胎龄儿的早产:一项前瞻性研究。
BJOG. 2024 Jul;131(8):1089-1101. doi: 10.1111/1471-0528.17752. Epub 2024 Jan 9.
8
Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.胎盘生长因子与胎儿胎盘多普勒指标联合应用可可靠预测合并胎儿生长受限的妊娠早产情况。
Ultrasound Obstet Gynecol. 2024 May;63(5):635-643. doi: 10.1002/uog.27513.
9
Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.血管生成标志物在胎儿生长受限妊娠中的预后价值。
Ultrasound Obstet Gynecol. 2024 May;63(5):619-626. doi: 10.1002/uog.27509.
10
Hypertensive disorders of pregnancy.妊娠高血压疾病。
BMJ. 2023 Jun 30;381:e071653. doi: 10.1136/bmj-2022-071653.